Skip to main content


COOPERATIVE OF SCIENTISTS

i+Med is a pharmaceutical company where the people behind the project are also its owners. This shared ownership fosters involvement and commitment to bringing science to market and improving people’s health.

We nurture talent

We drive research

We manufacture and market

We reinvest profits

WEB_06_26_I+MED 21.webp

PEOPLE

We firmly believe in science, but above all, we believe in the people who make it possible.

We firmly believe in science, but above all, we believe in the people who make it possible.

Every breakthrough, product and solution begins with talent. Our team comprises more than 200 professionals, including over 100 researchers who work every day to bring the medicine of the future closer to society.

At i+MED our technology is born of people.

At i+MED our technology is born of people.

Each advance, each patent and every solution we develop carries behind the gaze, experience and dedication of a scientist or scientist who promotes this project.

Dra. VIRGINIA SÁEZ

Dra. VIRGINIA SÁEZ

Coordinadora ciéntifica

Virginia is part of the team developing our nanocarriers, a technology that improves the absorption and efficacy of active compounds. Her work helps transform scientific knowledge into increasingly precise solutions within a cooperative that already holds 14 technology patents.

JOSÉ MARÍA ALONSO

JOSÉ MARÍA ALONSO

R&D Reasercher

Txema investigates how to ensure that an active compound reaches exactly where it is needed. Using nanocarriers, he works on tiny capsules that enable controlled transport and release. This technology draws on more than 13 years of collaborative research at i+Med.

RAÚL PÉREZ

RAÚL PÉREZ

Director Científico de i+Med

Raúl works on the development of nanohydrogels, nanoscale materials that allow for greater penetration and precision. His research is part of the knowledge shared by the more than 100 researchers at i+Med, where every advance is also the result of teamwork.

Technology

We promote research and innovation in personalized medicine.

We promote research and innovation in personalized medicine.

Our own advanced technology enables you to turn science into innovative solutions transferable to the market.

Installations

5,000 m² designed for advanced research and production.

5,000 m² designed for advanced research and production.

We have infrastructures designed to integrate research, development and production. guaranteeing quality, efficiency and scalability.

BUSINESS

From idea to market.

From idea to market.

A comprehensive approach that combines science, technology and industry. Our 360º capacity and our own technology allow us to transform innovation into real solutions.

We generate sustainable value and reinvest in growth and capacities.

Curva.webp

I+MED Group

The cooperative has grown organically.

Promoting R+D+i projects, promoted both internally and externally, to deliver new products and cutting-edge technologies

Agrupar.webp